BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8203052)

  • 1. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
    Tanaka K; Takashi M; Miyake K; Koshikawa T
    Urol Int; 1994; 52(3):140-4. PubMed ID: 8203052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
    Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
    Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of bladder cancer using the epithelial surface marker epithelial membrane antigen: a preliminary report.
    Ring KS; Karp F; Benson MC
    J Occup Med; 1990 Sep; 32(9):904-9. PubMed ID: 2074517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
    Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
    J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test.
    Del Nero A; Esposito N; Currò A; Biasoni D; Montanari E; Mangiarotti B; Trinchieri A; Zanetti G; Serrago MP; Pisani E
    Eur Urol; 1999 Feb; 35(2):93-7. PubMed ID: 9933801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers.
    Muraoka K; Nabeshima K; Murayama T; Biswas C; Koono M
    Int J Cancer; 1993 Aug; 55(1):19-26. PubMed ID: 8344748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder.
    Takashi M; Murase T; Kinjo T; Mitsuya H; Nagura H
    Urol Int; 1987; 42(3):170-5. PubMed ID: 3303592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
    Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
    Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of therapy on carcinoembryonic antigen activity in the urines of patients with cancer of the bladder.
    James K; Alroy J; Miller AW; Flanagan M
    Am J Clin Pathol; 1980 Feb; 73(2):250-3. PubMed ID: 6766663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
    Lekili M; Sener E; Demir MA; Temeltaş G; Müezzinoğlu T; Büyüksu C
    Urol Res; 2004 May; 32(2):124-8. PubMed ID: 14685796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Zitella A; Pelucelli G; Formiconi A; Priolo G; Martinasso G; Mengozzi G; Aimo G; Viberti L; Tizzani A
    Urol Int; 2000; 65(2):100-5. PubMed ID: 11025432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
    Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DD23 Biomarker: a prospective clinical assessment in routine urinary cytology specimens from patients being monitored for TCC.
    Sawczuk IS; Pickens CL; Vasa UR; Ralph DA; Norris KA; Miller MC; Ng AY; Grossman HB; Veltri RW
    Urol Oncol; 2002; 7(5):185-90. PubMed ID: 12644214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.